Commission Implementing Regulation (EU) 2021/620 of 15 April 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases (Text with EEA relevance)

COMMISSION IMPLEMENTING REGULATION (EU) 2021/620 of 15 April 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases (Text with EEA relevance)

Article 1

Subject matter and scope

This Regulation lists in the Annexes thereto:

(a) the Member States or zones or compartments thereof with approved compulsory eradication programmes for Category B diseases and optional eradication programmes for Category C diseases.

(b) the Member States or zones thereof with approved disease-free status and non-vaccination status;

(c) the compartments of Member States with recognised disease-free status.

Article 2

Infection with Brucella abortus, B. melitensis and B. suis

Article 3

Infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) (MTBC)

Article 4

Infection with rabies virus (RABV)

Article 5

Enzootic bovine leukosis (EBL)

Article 6

Infectious bovine rhinotracheitis/infectious pustular vulvovaginitis (IBR/IPV)

Article 7

Infection with Aujeszky’s disease virus(ADV)

Article 8

Bovine viral diarrhoea (BVD)

Article 9

Infection with bluetongue virus (serotypes 1-24) (infection with BTV)

Article 10

Infestation with Varroa spp.

The Member States or zones thereof with disease-free status from infestation with Varroa spp. shall be listed in Annex IX.

Article 11

Infection with Newcastle disease virus

The Member States or zones thereof with disease-free status from infection with Newcastle disease virus without vaccination shall be listed in Annex X.

Article 12

Infection with highly pathogenic avian influenza (HPAI)

Compartments of the Member States free from HPAI shall be listed in Annex XI.

Article 13

Viral haemorrhagic septicaemia (VHS)

The following shall be listed in Part I of Annex XII:

(a) Member States where their whole territory has disease-free status from viral haemorrhagic septicaemia (VHS);

(b) zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from VHS; and

(c) zones or compartments of Member States with disease-free status from VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

The following shall be listed in Part II of Annex XII:

(a) Member States where their whole territory has an approved eradication programme for VHS;

(b) zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for VHS; and

(c) zones and compartments of Member States with an approved eradication programme for VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

Article 14

Infectious haematopoietic necrosis (IHN)

The following shall be listed in Part I of Annex XIII:

(a) Member States where their whole territory has disease-free status from infectious haematopoietic necrosis (IHN);

(b) zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from IHN; and

(c) zones or compartments of Member States with disease-free status from IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

The following shall be listed in Part II of Annex XIII:

(a) Member States where their whole territory has an approved eradication programme for IHN;

(b) zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for IHN; and

(c) zones and compartments of Member States with an approved eradication programme for IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

Article 15

Infection with highly polymorphic region deleted infectious salmon anaemia virus (HPR-deleted ISAV)

The following shall be listed in Part I of Annex XIV:

(a) Member States where their whole territory has disease-free status from infection with highly polymorphic region deleted infectious salmon anaemia virus (HPR-deleted ISAV);

(b) zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with HPR-deleted ISAV; and

(c) zones or compartments of Member States with disease-free status from infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

The following shall be listed in Part II of Annex XIV:

(a) Member States where their whole territory has an approved eradication programme for infection with HPR-deleted ISAV;

(b) zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with HPR-deleted ISAV; and

(c) zones and compartments of Member States with an approved eradication programme for infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

Article 16

Infection with Marteilia refringens

The following shall be listed in Part I of Annex XV:

(a) Member States where their whole territory has disease-free status from infection with Marteilia refringens;

(b) zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Marteilia refringens; and

(c) zones or compartments of Member States with disease-free status from infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

The following shall be listed in Part II of Annex XV:

(a) Member States where their whole territory has an approved eradication programme for infection with Marteilia refringens;

(b) zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Marteilia refringens; and

(c) zones and compartments of Member States with an approved eradication programme for infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

Article 17

Infection with Bonamia exitiosa

The following shall be listed in Part I of Annex XVI:

(a) Member States where their whole territory has disease-free status from infection with Bonamia exitiosa;

(b) zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia exitiosa; and

(c) zones or compartments of Member States with disease-free status from infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

The following shall be listed in Part II of Annex XVI:

(a) Member States where their whole territory has an approved eradication programme for infection with Bonamia exitiosa;

(b) zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia exitiosa; and

(c) zones and compartments of Member States with an approved eradication programme for infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

Article 18

Infection with Bonamia ostreae

The following shall be listed in Part I of Annex XVII:

(a) Member States where their whole territory has disease-free status from infection with Bonamia ostreae;

(b) zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia ostreae; and

(c) zones or compartments of Member States with disease-free status from infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

The following shall be listed in Part II of Annex XVII:

(a) Member States where their whole territory has an approved eradication programme for infection with Bonamia ostreae;

(b) zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia ostreae; and

(c) zones and compartments of Member States with an approved eradication programme for infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

Article 19

Infection with white spot syndrome virus (WSSV)

The following shall be listed in Part I of Annex XVIII:

(a) Member States where their whole territory has disease-free status from infection with white spot syndrome virus (WSSV);

(b) zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with WSSV; and

(c) zones or compartments of Member States with disease-free status from infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

The following shall be listed in Part II of Annex XVIII:

(a) Member States where their whole territory has an approved eradication programme for infection with WSSV;

(b) zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with WSSV; and

(c) zones and compartments of Member States with an approved eradication programme for infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

Article 20

Repeal

The following acts are repealed:

— Decision 93/52/EEC,

— Decision 94/963/EC,

— Decision 95/98/EC,

— Decision 2003/467/EC,

— Decision 2004/558/EC,

— Decision 2008/185/EC,

— Decision 2009/177/EC,

— Regulation (EC) No 616/2009,

— Implementing Decision 2013/503/EU.

Article 21

Entry into force and application

This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union.

It shall apply from 21 April 2021.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

ANNEX I

PART I

Disease-free status from infection with Brucella abortus, B. melitensis and B. suis

CHAPTER 1

Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in bovine animal populations

Member State (*1)	Territory
Belgium	Whole territory
Czechia	Whole territory
Denmark	Whole territory
Germany	Whole territory
Estonia	Whole territory
Ireland	Whole territory
Spain	Whole territory
France	Whole territory
Croatia	Whole territory
Italy	Regione Abruzzo: Provincia di Pescara, Teramo, Chieti Regione Basilicata: Provincia di Matera Regione Calabria: Provincia di Vibo Valentia Regione Campania: Provincia di Avellino, Benevento, Napoli Regione Emilia-Romagna Regione Friuli Venezia Giulia Regione Lazio Regione Liguria Regione Lombardia Regione Marche Regione Molise Regione Piemonte Regione Puglia: Provincia di Bari, Barletta-Andria-Trani, Brindisi, Lecce Regione Sicilia: Provincia de Agrigento, Trapani, Caltanissetta Regione Sardegna Regione Toscana Regione Trentino – Alto Adige Regione Umbria Regione Valle d’Aosta Regione Veneto
Cyprus	Whole territory
Latvia	Whole territory
Lithuania	Whole territory
Luxembourg	Whole territory
Hungary	Whole territory
Malta	Whole territory
Netherlands	Whole territory
Austria	Whole territory
Poland	Whole territory
Portugal	Distritos Aveiro, Castelo Branco, Coimbra, Faro, Guarda, Leiria, Santarem, Setubal, Viseu Região Autónoma dos Açores: Ilhas de Corvo, Faial, Flores, Graciosa, Pico, São Jorge, Santa Maria, Terceira
Romania	Whole territory
Slovenia	Whole territory
Slovakia	Whole territory
Finland	Whole territory
Sweden	Whole territory
United Kingdom (Northern Ireland)	Northern Ireland
(*1) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

CHAPTER 2

Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations

Member State (*1)	Territory
Belgium	Whole territory
Czechia	Whole territory
Denmark	Whole territory
Germany	Whole territory
Estonia	Whole territory
Ireland	Whole territory
Spain	Whole territory
France	Whole territory
Croatia	Whole territory
Italy	Regione Abruzzo Regione Basilicata: Province di Matera Regione Calabria: Province di Catanzaro, Cosenza Regione Campania: Provincia di Benevento, Napoli, Salerno Regione Emilia-Romagna Regione Friuli Venezia Giulia Regione Lazio Regione Liguria Regione Lombardia Regione Marche Regione Molise Regione Piemonte: Provincia de Asti, Biella, Cuneo, Novara, Verbano-Cusio-Ossola, Vercelli and Citta Metropolitana di Torino Regione Puglia: Province di Bari, Barletta-Andria-Trani, Brindisi, Lecce, Taranto Regione Sardegna Regione Toscana Regione Trentino – Alto Adige Regione Umbria Regione Valle d’Aosta Regione Veneto
Cyprus	Whole territory
Latvia	Whole territory
Lithuania	Whole territory
Luxembourg	Whole territory
Hungary	Whole territory
Netherlands	Whole territory
Austria	Whole territory
Poland	Whole territory
Portugal	Região Autónoma dos Açores
Romania	Whole territory
Slovenia	Whole territory
Slovakia	Whole territory
Finland	Whole territory
Sweden	Whole territory
United Kingdom (Northern Ireland)	Northern Ireland
(*1) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

PART II

Member States or zones thereof with an approved eradication programme for Brucella abortus, B. melitensis and B. suis

CHAPTER 1

Member States or zones thereof with an approved eradication programme for Brucella abortus, B. melitensis and B. suis in bovine animal populations

Member State	Territory
Bulgaria	Whole territory
Greece	Whole territory
—————
Italy	Regione Abruzzo: Provincia dell’Aquila, Regione Basilicata: Provincia di Potenza Regione Calabria: Provincia di Catanzaro, Cosenza, Crotone, Reggio Calabria Regione Campania: Provincia di Caserta, Salerno Regione Puglia: Provincia di Foggia, Taranto Regione Sicilia except the Provincia of Agrigento,Trapani, Caltanissetta
Portugal	Distritos Beja, Braga, Braganca, Evora, Lisboa, Portalegre, Porto, Viana do Castelo, Vila Real Região Autónoma da Madeira Região Autónoma dos Açores: Ilha de São Miguel

CHAPTER 2

Member States or zones thereof with an approved eradication programme for Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations

Member State	Territory
Bulgaria	Whole territor
—————
Greece	Whole territory
Italy	Regione Basilicata: Provincia di Potenza Regione Calabria: Province di Crotone, Reggio Calabria, Vibo Valentia Regione Campania: Provincia d’Avellino, Caserta Regione Piemonte: Provincia di Alessandria Regione Puglia: Provincia di Foggia Regione Sicilia
Portugal	Região Madeira Distritos Aveiro, Beja, Braga, Braganca, Castelo Branco, Coimbra, Evora, Faro, Guarda, Leiria, Lisboa, Portalegre, Porto, Santarem, Setubal, Viana do Castelo, Vila Real, Viseu

ANNEX II

PART I

Member States or zones thereof with disease-free status from infection with MTBC

Member State	Territory
Belgium	Whole territory
Czechia	Whole territory
Denmark	Whole territory
Germany	Whole territory
Estonia	Whole territory
Spain	Comunidad Autónoma de Canarias Comunidad Autónoma de Castilla y León: Province of Burgos, León, Valladolid Comunidad Autónoma de Cataluña Comunidad Autónoma de Galicia Comunidad Autónoma de Islas Baleares Comunidad Autónoma de Murcia Comunidad Autónoma del País Vasco Comunidad Autónoma del Principado de Asturias
France	Whole territory
Croatia	Whole territory
Italy	Regione Abruzzo Regione Basilicata: Provincia di Matera Regione Calabria: Provincia di Catanzaro Regione Campania: Provincia di Napoli Regione Emilia-Romagna Regione Friuli Venezia Giulia Regione Lazio: Province di Frosinone, Latina, Rieti, Viterbo Regione Liguria Regione Lombardia Regione Marche: Province di Ancona, Ascoli Piceno, Fermo, Pesaro-Urbino Regione Molise Regione Piemonte Regione Puglia: Province di Bari, Barletta-Andria-Trani, Brindisi, Lecce, Taranto Regione Sardegna Regione Toscana Regione Trentino – Alto Adige Regione Umbria Regione Valle d’Aosta Regione Veneto
Latvia	Whole territory
Lithuania	Whole territory
Luxembourg	Whole territory
Hungary	Whole territory
Netherlands	Whole territory
Austria	Whole territory
Poland	Whole territory
Portugal	Região Algarve: all distritos Região Autónoma dos Açores except Ilha de São Miguel
Slovenia	Whole territory
Slovakia	Whole territory
Finland	Whole territory
Sweden	Whole territory

PART II

Member States or zones thereof with an approved eradication programme for infection with MTBC

Member State (*1)	Territory
Bulgaria	Whole territory
—————
Cyprus	Whole territory
Greece	Whole territory
Ireland	Whole territory
Italy	Regione Basilicata: Provincia di Potenza Regione Calabria: Province di Cosenza, Crotone, Reggio Calabria, Vibo Valentia Regione Campania: Province d’Avellino, Caserta, Benevento, Salerno Regione Lazio: Provincia di Roma Regione Marche: Provincia di Macerata Regione Puglia: Provincia di Foggia Regione Sicilia
Malta	Whole territory
Portugal	Região Autónoma dos Açores: Ilha de São Miguel Região Autónoma da Madeira Distritos Aveiro, Beja, Braga, Bragança, Castelo Branco, Coimbra, Evora, Guarda, Leiria, Lisboa, Portalegre, Porto, Santarem, Setubal, Viana do Castelo, Vila Real, Viseu
Romania	Whole territory
Spain	Comunidad Autónoma de Andalucía Comunidad Autónoma de Aragón Comunidad Autónoma de Cantabria Comunidad Autónoma de Castilla-La Mancha Comunidad Autónoma de Castilla y León: Province of Ávila, Palencia, Salamanca, Segovia, Soria, Zamora Comunidad Autónoma de Extremadura Comunidad Autónoma de La Rioja Comunidad Autónoma de Madrid Comunidad Autónoma de Navarra Comunidad Autónoma de Valencia
United Kingdom (Northern Ireland)	Northern Ireland
(*1) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

ANNEX III

PART I

Member States or zones thereof with disease-free status from infection with RABV

Member State (*1)	Territory
Belgium	Whole territory
Bulgaria	Whole territory
Czechia	Whole territory
Denmark	Whole territory
Germany	Whole territory
Estonia	Whole territory
Ireland	Whole territory
Greece	Whole territory
Spain	Whole territory
France	Whole territory
Croatia	Whole territory
Italy	Whole territory
Cyprus	Whole territory
Latvia	Whole territory
Lithuania	Whole territory
Luxembourg	Whole territory
Hungary	Whole territory except Szabolcs-Szatmár-Bereg megye
Malta	Whole territory
Netherlands	Whole territory
Austria	Whole territory
Poland	Voivodship Dolnośląskie: all powiaty Voivodship Kujawsko-pomorskie: all powiaty Voivodship Lubelskie the following powiaty: łukowski, rycki, puławski, opolski, kraśnicki, janowski, lubelski, m. Lublin, lubartowski, radzyński, parczewski, bialski, m. Biała Podlaska Voivodship Lubuskie: all powiaty Voivodship Łódzkie: all powiaty Voivodship Małopolskie: all powiaty Voivodship Mazowieckie: all powiaty Voivodship Opolskie: all powiaty Voivodeship Podkarpackie the following powiaty: stalowowolski, tarnobrzeski, m. Tarnobrzeg, niżański, leżajski, łańcucki Voivodship Podlaskie: all powiaty Voivodship Pomorskie: all powiaty Voivodship Śląskie: all powiaty Voivodship Świętokrzyskie: all powiaty Voivodship Warmińsko-mazurskie: all powiaty Voivodship Wielkopolskie: all powiaty Voivodship Zachodniopomorskie: all powiaty
Portugal	Whole territory
Slovenia	Whole territory
Slovakia	Whole territory, except the following regions: Humenné, Medzilaborce, Snina, Stropkov, Svidnik, Vranov nad Topl’ou in kraj Prešovský Michalovce, Sobrance, Trebišov in kraj Košický
Finland	Whole territory
Sweden	Whole territory
United Kingdom (Northern Ireland)	Northern Ireland
(*1) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

PART II

Member States or zones thereof with an approved eradication programme for infection with RABV

Member State	Territory
Hungary	Szabolcs-Szatmár-Bereg megye
Poland	Voivodship Lubelskie the following powiaty: włodawski, łęczyński, świdnicki, krasnostawski, zamojski, m. Zamość, biłgorajski, chełmski, m. Chełm, hrubieszowski, tomaszowski Voivodship Podkarpackie: the following powiaty: lubaczowski, przeworski, jarosławski, rzeszowski, m. Rzeszów, strzyżowski, krośnieński, m. Krosno, sanocki, leski, bieszczadzki, przemyski, m. Przemyśl, Brzozowski, ropczycko-sędziszowski, jasielski, dębicki, mielecki, kolbuszowski
Romania	Whole territory
Slovakia	Region Humenné, Medzilaborce, Snina, Stropkov, Svidnik, Vranov nad Topl’ou in kraj Prešovský Region Michalovce, Sobrance, Trebišov in kraj Košický

ANNEX IV

PART I

Member States or zones thereof with disease-free status from EBL

Member State (*1)	Territory
Belgium	Whole territory
Czechia	Whole territory
Denmark	Whole territory
Germany	Whole territory
Estonia	Whole territory
Ireland	Whole territory
Spain	Whole territory
France	Région Auvergne et Rhône-Alpes Région Bourgogne-Franche-Comté Région Bretagne Région Centre-Val de Loire Région Corse Région Grande Est Région Hauts-de-France Région Ile-de-France Région Normandie Région Nouvelle-Aquitaine Région Occitanie Région Pays de la Loire Région Provence-Alpes-Côte d’Azur Région Guadeloupe Région Guyane Région Martinique Région Mayotte
Croatia	Whole territory
Italy	Whole territory
Cyprus	Whole territory
Latvia	Whole territory
Lithuania	Whole territory
Luxembourg	Whole territory
Netherlands	Whole territory
Austria	Whole territory
Poland	Whole territory
Portugal	Whole territory, except Região Autónoma da Madeira
Slovenia	Whole territory
Slovakia	Whole territory
Finland	Whole territory
Sweden	Whole territory
United Kingdom (Northern Ireland)	Northern Ireland
(*1) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

PART II

Member States or zones thereof with an approved eradication programme for EBL

Member State	Territory	Date of initial approval as referred to in Article 15(2) of Delegated Regulation (EU) 2020/689
—————

ANNEX V

PART I

Member States or zones thereof with disease-free status from IBR/IPV

Member State	Territory
Czechia	Whole territory
Denmark	Whole territory
Germany	Whole territory
Italy	Regione Valle d’Aosta Regione Trentino – Alto Adige: Provincia Autonoma di Bolzano – Alto Adige
Austria	Whole territory
Finland	Whole territory
Sweden	Whole territory

PART II

Member States or zones thereof with an approved eradication programme for IBR/IPV

Member State	Territory	Date of initial approval as referred to in point 2 of Article 15 of Delegated Regulation (EU) 2020/689
Belgium	Whole territory	21 April 2021
France	Région Auvergne et Rhône-Alpes Région Bourgogne-Franche-Comté Région Bretagne Région Centre-Val de Loire Région Grande Est Région Hauts-de-France Région Ile-de-France Région Normandie Région Nouvelle-Aquitaine Région Occitanie Région Pays de la Loire Région Provence-Alpes-Côte d’Azur	21 April 2021
Italy	Region Friuli Venezia Giulia Regione Trentino – Alto Adige: Provincia Autonoma di Trento	21 April 2021
Luxembourg	Whole territory	21 April 2021
Slovakia	Kraj Bratislava Kraj Košice Kraj Prešov Kraj Trnava Kraj Žilina	5 June 2023

ANNEX VI

PART I

Member States or zones thereof with disease-free status from infection with ADV

Member State (*1)	Territory
Belgium	Whole territory
Czechia	Whole territory
Denmark	Whole territory
Germany	Whole territory
Estonia	Whole territory
Ireland	Whole territory
France	The departments of Ain, Aisne, Allier, Alpes-de-Haute-Provence, Alpes-Maritimes, Ardèche, Ardennes, Ariège, Aube, Aude, Aveyron, Bas-Rhin, Bouches-du-Rhône, Calvados, Cantal, Charente, Charente-Maritime, Cher, Corrèze, Côte-d’Or, Côtes-d’Armor, Creuse, Deux-Sèvres, Dordogne, Doubs, Drôme, Essonne, Eure, Eure-et-Loir, Finistère, Gard, Gers, Gironde, Hautes-Alpes, Hauts-de-Seine, Haute Garonne, Haute-Loire, Haute-Marne, Hautes-Pyrénées, Haut-Rhin, Haute-Saône, Haute-Savoie, Haute-Vienne, Hérault, Indre, Ille-et-Vilaine, Indre-et-Loire, Isère, Jura, Landes, Loire, Loire-Atlantique, Loir-et-Cher, Loiret, Lot, Lot-et-Garonne, Lozère, Maine-et-Loire, Manche, Marne, Mayenne, Meurthe-et-Moselle, Meuse, Morbihan, Moselle, Nièvre, Nord, Oise, Orne, Paris, Pas-de-Calais, Pyrénées-Atlantiques, Pyrénées-Orientales, Puy-de-Dôme, Réunion, Rhône, Sarthe, Saône-et-Loire, Savoie, Seine-et-Marne, Seine-Maritime, Seine-Saint-Denis, Somme, Tarn, Tarn-et-Garonne, Territoire de Belfort, Val-de-Marne, Val-d’Oise, Var, Vaucluse, Vendée, Vienne, Vosges, Yonne, Yvelines
Italy	Regione Friuli Venezia Giulia Regione Trentino – Alto Adige Regione Veneto
Cyprus	Whole territory
Luxembourg	Whole territory
Hungary	Whole territory
Netherlands	Whole territory
Austria	Whole territory
Poland	Whole territory
Portugal	Região Autónoma dos Açores
Slovenia	Whole territory
Slovakia	Whole territory
Finland	Whole territory
Sweden	Whole territory
United Kingdom (Northern Ireland)	Northern Ireland
(*1) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

PART II

Member States or zones thereof with an approved eradication programme for infection with ADV

Member State	Territory	Date of initial approval as referred to in point 2 of Article 15 of Delegated Regulation (EU) 2020/689
Spain	Whole territory	21 April 2021
Italy	Regione Abruzzo Regione Apulia Regione Basilicata Regione Calabria Regione Campania Regione Emilia-Romagna Regione Lazio Regione Liguria Regione Lombardia Regione Marche Regione Molise Regione Piemonte Regione Sicilia Regione Toscana Regione Valle d’Aosta Regione Umbria	21 April 2021
Lithuania	Whole territory	21 April 2021
—————
Portugal	Whole peninsular territory	21 April 2021

ANNEX VII

PART I

Member States or zones thereof with disease-free status from BVD

Member State	Territory
Austria	Whole territory
Denmark	Whole territory
Finland	Whole territory
Germany	Bundesland Baden-Württemberg Bundesland Bayern Bundesland Brandenburg Bundesland Bremen Bundesland Hamburg Bundesland Hessen Bundesland Mecklenburg-Vorpommern Bundesland Niedersachsen, except Landkreis Cuxhaven Bundesland Nordrhein-Westfalen, except Kreis Höxter Bundesland Schleswig-Holstein Bundesland Rheinland-Pfalz Bundesland Saarland Bundesland Sachsen Bundesland Sachsen-Anhalt Bundesland Thüringen
Sweden	Whole territory

PART II

Member States or zones thereof with an approved eradication programme for BVD

Member State	Territory	Date of initial approval as referred to in Article 15(2) of Delegated Regulation (EU) 2020/689
Germany	Bundesland Berlin Bundesland Niedersachsen: Landkreis Cuxhaven Bundesland Nordrhein-Westfalen: Kreis Höxter	21.2.2022
Ireland	Whole territory	18 July 2022

ANNEX VIII

PART I

Member States or zones thereof with disease-free status from infection with BTV

Member State (*1)	Territory
—————
—————
—————
Estonia	Whole territory
Ireland	Whole territory
Spain	Comunidad Autónoma de Canarias
—————
Latvia	Whole territory
—————
—————
—————
—————
—————
Poland	The whole territory of Poland except: województwo dolnośląskie; województwo kujawsko-pomorskie; województwo lubuskie; województwo łódzkie; województwo opolskie; województwo pomorskie; województwo śląskie; województwo wielkopolskie; województwo zachodniopomorskie; w województwie małopolskim: — powiat chrzanowski, — powiat krakowski, — miasto na prawach powiatu Kraków, — powiat limanowski, — powiat miechowski, — powiat myślenicki, — powiat nowotarski, — powiat olkuski, — powiat oświęcimski, — powiat suski, — powiat wadowicki, — w powiecie proszowickim: gmina Koniusza, gmina Radziemice, — w powiecie wielickim: gmina Biskupice, gmina Gdów, gmina Niepołomice, gmina Wieliczka; w województwie mazowieckim: — powiat gostyniński, — powiat mławski, — powiat płocki, — miasto na prawach powiatu Płock, — powiat przasnyski, — powiat sierpecki, — powiat żuromiński, — w powiecie ciechanowskim: gmina Ciechanów, miasto Ciechanów, gmina Glinojeck, gmina Grudusk, gmina Opinogóra Górna, gmina Regimin, — w powiecie makowskim: gmina Krasnosielc, gmina Płoniawy-Bramura, gmina Sypniewo, — w powiecie ostrołęckim: gmina Baranowo, gmina Czarnia, gmina Kadzidło, gmina Lelis, gmina Łyse, gmina Myszyniec, gmina Olszewo-Borki, — w powiecie płońskim: gmina Baboszewo, gmina Czerwińsk nad Wisłą, gmina Dzierzążnia, gmina Naruszewo, gmina Raciąż, miasto Raciąż, — w powiecie sochaczewskim: gmina Brochów, gmina Iłów, gmina Młodzieszyn, gmina Nowa Sucha, gmina Rybno, gmina Sochaczew, miasto Sochaczew; w województwie podlaskim: — w powiecie kolneńskim: gmina Kolno, miasto Kolno, gmina Turośl, — w powiecie łomżyńskim: gmina Zbójna; w województwie świętokrzyskim: — w powiecie jędrzejowskim: gmina Nagłowice, gmina Sędziszów, gmina Słupia (Jędrzejowska), gmina Wodzisław, — w powiecie włoszczowskim: gmina Kluczewsko, gmina Moskorzew, gmina Radków, gmina Secemin, gmina Włoszczowa; w województwie warmińsko-mazurskim: — powiat bartoszycki, — powiat braniewski, — powiat działdowski, — powiat elbląski, — miasto na prawach powiatu Elbląg, — powiat giżycki, — powiat iławski, — powiat kętrzyński, — powiat lidzbarski, — powiat mrągowski, — powiat nidzicki, — powiat nowomiejski, — powiat olsztyński, — miasto na prawach powiatu Olsztyn, — powiat ostródzki, — powiat piski, — powiat szczycieński, — powiat węgorzewski, — w powiecie ełckim: gmina Ełk, miasto Ełk, gmina Stare Juchy, — w powiecie gołdapskim: gmina Banie Mazurskie, gmina Gołdap, — w powiecie oleckim: gmina Kowale Oleckie, gmina Świętajno.
Portugal	Região Autónoma dos Açores Região Autónoma da Madeira
—————
Slovakia	Whole territory
Finland	Whole territory
—————
—————
(*1) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

PART II

Member States or zones thereof with an approved eradication programme for infection with BTV

Member State	Territory	Date of initial approval as referred to in Article 15(2) of Delegated Regulation (EU) 2020/689
Spain	Comunidad Autónoma de las Islas Baleares	21.10.2024

ANNEX IX

Member States or zones thereof with disease-free status from infestation with Varroa spp.

Member State	Territory
Portugal	Island of Corvo Island of Graciosa Island of São Jorge Island of Santa Maria Island of São Miguel Island of Terceira
Finland	Åland Islands, except the municipality of Brändö

ANNEX X

Member States or zones thereof with disease-free status from infection with Newcastle disease virus without vaccination

Member State	Territory
Finland	Whole territory
Sweden	Whole territory

ANNEX XI

Compartments free from HPAI

Member State	Name
France	ISA Bretagne, consisting in the establishments EDE 22080055, EDE 22277180, EDE 22203429, EDE 22059174 and EDE 22295000; SASSO Sabres, consisting in the establishment EDE 40246082; SASSO Soulitré, consisting in the establishment EDE 72341105.
The Netherlands	Institut de selection animale B.V, with approval number 2338, consisting in the following companies: — Institut de Selection Animale B.V., St. Anthonisweg 65 B, 5831 AD Boxmeer — ISA Siebengewald, Horsterbeekweg 5, 5853 GD Siebengewald — ISA Landhorst, Boekelsebaan 16, 5445 NH Landhorst — Mts. Everts, Riegshoogtendijk 146, 7913 TC Hollandscheveld — Mts. Van der Zee, Bakkeveenseweg 1, 9343 TB Een-West — Scherpenkate, Oosterkampen 2, 7722 VZ Dalfsen — Mts. Steverink, Dinxperloseweg 26b, 7064 LA Silvolde — Melitz V.O.F. Zeewolde, Ooievaarsweg 5, 3897 LG, Zeewolde.

ANNEX XII

PART I

Member States whose whole territory has disease-free status from VHS;

zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from VHS; and

zones or compartments of Member States with disease-free status from VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

Member State (*1)	Territory
Denmark	Whole territory
Estonia	Whole territory
Ireland	Whole territory
Cyprus	Whole continental territory
Finland	Whole territory
Sweden	Whole territory
United Kingdom (Northern Ireland)	Northern Ireland
(*1) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

PART II

Member States where their whole territory has an approved eradication programme for VHS;

zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for VHS;

and zones and compartments of Member States with an approved eradication programme for VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

Member State	Territory	Date of initial approval as referred to in point 2 of Article 49 of Delegated Regulation (EU) 2020/689
—————

ANNEX XIII

PART I

Member States where their whole territory has disease-free status from IHN;

zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from IHN;

and zones or compartments of Member States with disease-free status from IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

Member State (*1)	Territory
—————
Estonia	Whole territory
Ireland	Whole territory
Cyprus	Whole continental territory
Finland	Whole territory
Sweden	Whole territory
United Kingdom (Northern Ireland)	Northern Ireland
(*1) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

PART II

Member States where their whole territory has an approved eradication programme for IHN;

zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for IHN; and

zones and compartments of Member States with an approved eradication programme for IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

Member State	Territory	Date of initial approval as referred to in point 2 of Article 49 of Delegated Regulation (EU) 2020/689
—————

ANNEX XIV

PART I

Member States where their whole territory has disease-free status from infection with HPR-deleted ISAV;

zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with HPR-deleted ISAV; and

zones or compartments of Member States with disease-free status from infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

Member State (*1)	Territory
Belgium	Whole territory
Bulgaria	Whole territory
Czechia	Whole territory
Denmark	Whole territory
Germany	Whole territory
Estonia	Whole territory
Ireland	Whole territory
Greece	Whole territory
Spain	Whole territory
France	Whole territory
Croatia	Whole territory
Italy	Whole territory
Cyprus	Whole territory
Latvia	Whole territory
Lithuania	Whole territory
Luxembourg	Whole territory
Hungary	Whole territory
Malta	Whole territory
Netherlands	Whole territory
Austria	Whole territory
Poland	Whole territory
Portugal	Whole territory
Romania	Whole territory
Slovenia	Whole territory
Slovakia	Whole territory
Finland	Whole territory
Sweden	Whole territory
United Kingdom (Northern Ireland)	Northern Ireland
(*1) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

PART II

Member States where their whole territory has an approved eradication programme for infection with HPR-deleted ISAV;

zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with HPR-deleted ISAV; and

zones and compartments of Member States with an approved eradication programme for infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

None at present.

ANNEX XV

PART I

Member States where their whole territory has disease-free status from infection with Marteilia refringens;

zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Marteilia refringens; and

zones or compartments of Member States with disease-free status from infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

Member State (*1)	Territory
Ireland	Whole territory
Sweden	Whole territory
United Kingdom (Northern Ireland)	The whole coastline of Northern Ireland, except for Belfast Lough and Dundrum Bay.
(*1) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

PART II

Member States where their whole territory has an approved eradication programme for infection with Marteilia refringens;

zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Marteilia refringens; and

zones and compartments of Member States with an approved eradication programme for infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

None at present.

ANNEX XVI

PART I

Member States where their whole territory has disease-free status from infection with Bonamia exitiosa;

zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia exitiosa; and

zones or compartments of Member States with disease-free status from infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

Member State	Territory
Estonia	Whole territory
Sweden	Whole territory

PART II

Member States where their whole territory has an approved eradication programme for infection with Bonamia exitiosa;

zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia exitiosa; and

zones and compartments of Member States with an approved eradication programme for infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

None at present.

ANNEX XVII

PART I

Member States where their whole territory has disease-free status from infection with Bonamia ostreae;

zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia ostreae; and

zones or compartments of Member States with disease-free status from infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

Member State (*1)	Territory
Estonia	Whole territory
Ireland	The whole coastline of Ireland, except: Cork Harbour; Galway Bay; Ballinakill Harbour; Clew Bay; Achill Sound; Loughmore, Blacksod Bay; Lough Foyle; Lough Swilly; and Kilkieran Bay.
Sweden	Whole territory
United Kingdom (Northern Ireland)	The whole coastline of Northern Ireland, except: Lough Foyle and Strangford Lough.
(*1) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

PART II

Member States where their whole territory has an approved eradication programme for infection with Bonamia ostreae;

zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia ostreae; and

zones and compartments of Member States with an approved eradication programme for infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

None at present.

ANNEX XVIII

PART I

Member States where their whole territory has disease-free status from infection with WSSV;

zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with WSSV; and

zones or compartments of Member States with disease-free status from infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

None at present.

PART II

Member States where their whole territory has an approved eradication programme for infection with WSSV;

zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with WSSV; and

zones and compartments of Member States with an approved eradication programme for infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

None at present.